<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK2534" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK2534/" /><meta name="ncbi_pagename" content="FLNB-Related Disorders - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>FLNB-Related Disorders - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="FLNB-Related Disorders" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2013/10/17" /><meta name="citation_author" content="Stephen Robertson" /><meta name="citation_pmid" content="20301736" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK2534/" /><meta name="citation_keywords" content="Atelosteogenesis Type I" /><meta name="citation_keywords" content="Atelosteogenesis Type III" /><meta name="citation_keywords" content="Larsen Syndrome" /><meta name="citation_keywords" content="Spondylocarpotarsal Synostosis Syndrome" /><meta name="citation_keywords" content="Boomerang Dysplasia" /><meta name="citation_keywords" content="Filamin-B" /><meta name="citation_keywords" content="FLNB" /><meta name="citation_keywords" content="FLNB-Related Disorders" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="FLNB-Related Disorders" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Stephen Robertson" /><meta name="DC.Date" content="2013/10/17" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK2534/" /><meta name="description" content="The FLNB-related disorders include a spectrum of phenotypes ranging from mild (spondylocarpotarsal synostosis [SCT] syndrome and Larsen syndrome) to severe (atelosteogenesis types I [AOI] and III [AOIII], boomerang dysplasia)." /><meta name="og:title" content="FLNB-Related Disorders" /><meta name="og:type" content="book" /><meta name="og:description" content="The FLNB-related disorders include a spectrum of phenotypes ranging from mild (spondylocarpotarsal synostosis [SCT] syndrome and Larsen syndrome) to severe (atelosteogenesis types I [AOI] and III [AOIII], boomerang dysplasia)." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK2534/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/flnb-dis/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK2534/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8976E9E040E5F10000000003F101C8.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK2534_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK2534_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/x-pvh/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/fragilex/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK2534_"><span class="title" itemprop="name"><i>FLNB</i>-Related Disorders</span></h1><p class="contrib-group"><span itemprop="author">Stephen Robertson</span>, FRACP, DPhil.</p><a data-jig="ncbitoggler" href="#__NBK2534_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK2534_ai__"><div class="contrib half_rhythm"><span itemprop="author">Stephen Robertson</span>, FRACP, DPhil<div class="affiliation small">Professor of Paediatric Genetics<br />Department of Paediatrics and Child Health<br />Dunedin School of Medicine<br />University of Otago<br />Dunedin, New Zealand</div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 9, 2008</span>; Last Update: <span itemprop="dateModified">October 17, 2013</span>.</p><p><em>Estimated reading time: 23 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="flnb-dis.Summary" itemprop="description"><h2 id="_flnb-dis_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>The <i>FLNB</i>-related disorders include a spectrum of phenotypes ranging from mild (spondylocarpotarsal synostosis [SCT] syndrome and Larsen syndrome) to severe (atelosteogenesis types I [AOI] and III [AOIII], boomerang dysplasia).</p><p>SCT syndrome is characterized by disproportionate short stature, block vertebrae, scoliosis and lordosis, carpal and tarsal fusion, club feet, hearing loss, dental enamel hypoplasia, and mild facial dysmorphisms.</p><p>Larsen syndrome is characterized by <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> dislocations of the hip, knee, and elbow; club feet (equinovarus or equinovalgus foot deformities); scoliosis and cervical kyphosis, which can be associated with a cervical myelopathy; short, broad, spatulate distal phalanges; and distinctive craniofacies (prominent forehead, depressed nasal bridge, malar flattening, and widely spaced eyes). Both can have midline cleft palate and conductive hearing loss.</p><p>AOIII and AOI are characterized by severe short-limbed dwarfism; dislocated hips, knees, and elbows; and club feet. AOI is lethal in the perinatal period.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Diagnosis is based on clinical and radiographic findings and confirmed with <i>FLNB</i> <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Cervical spine instability in asymptomatic infants is successfully managed with posterior arthrodesis. Function can be stabilized, if not improved, in infants with myelopathic signs by a combination of anterior decompression and circumferential arthrodesis. Hip dislocation in Larsen syndrome usually requires operative reduction. Scoliosis and club feet are managed in a routine manner. When possible, cleft palate and hearing loss are best managed by multidisciplinary teams.</p><p><i>Prevention of secondary complications:</i> Preemptive posterior stabilization of the cervical spine in Larsen syndrome. When using general anesthesia: prior evaluation for evidence of cervical spine instability and minimizing of cervical spine extension intraoperatively; rapid induction and recovery when possible to reduce the risk of airway complications from laryngotracheomalacia.</p><p><i>Surveillance:</i> Monitoring in infancy for hip dislocation and later in childhood for progressive scoliosis.</p><p><i>Pregnancy management</i>: Delivery of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infant has the potential to be complicated by extended breech presentation due to dislocation of the hips and knees.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>AOI, AOIII, boomerang dysplasia, and Larsen syndrome are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. The proportion of autosomal dominant <i>FLNB</i>-related disorders caused by <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants is unknown, although the vast majority of lethal <i>FLNB</i>-related conditions are caused by <i>de novo</i> events. In rare instances, a parent with low-level <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> transmits the causative <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> offspring. Each child of an individual with an autosomal dominant <i>FLNB</i>-related disorder has a 50% chance of inheriting the pathogenic variant. Prenatal testing for pregnancies at increased risk for autosomal dominant <i>FLNB</i>-related disorders is possible if the pathogenic variant in the family is known.</p><p>SCT syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an individual with SCT syndrome has a 25% chance of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and prenatal testing for SCT syndrome are possible once the pathogenic variants have been identified in the family.</p></div></div><div id="flnb-dis.GeneReview_Scope"><h2 id="_flnb-dis_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="flnb-dis.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK2534/table/flnb-dis.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__flnb-dis.Tc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_flnb-dis.Tc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><i>FLNB</i>-Related Disorders: Included Phenotypes</th></tr></thead><tbody><tr><td headers="hd_h_flnb-dis.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Boomerang dysplasia</div></li><li class="half_rhythm"><div>Atelosteogenesis type I</div></li><li class="half_rhythm"><div>Atelosteogenesis type III</div></li><li class="half_rhythm"><div>Spondylocarpotarsal synostosis syndrome&#x000a0;<sup>1</sup></div></li><li class="half_rhythm"><div>Larsen syndrome&#x000a0;<sup>1</sup></div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#flnb-dis.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="flnb-dis.TF.c.1"><p class="no_margin">For other genetic causes of these pehnotypes see <a href="#flnb-dis.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="flnb-dis.Diagnosis"><h2 id="_flnb-dis_Diagnosis_">Diagnosis</h2><div id="flnb-dis.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>The <i>FLNB</i>-related disorders include a spectrum of phenotypes ranging from mild to severe. At the mild end are spondylocarpotarsal synostosis (SCT) syndrome and Larsen syndrome and at the severe end are the phenotypic continuum of atelosteogenesis types I (AOI) and III (AOIII) and boomerang dysplasia.</p><p><b>Spondylocarpotarsal synostosis (SCT) syndrome</b> is characterized by the following [<a class="bk_pop" href="#flnb-dis.REF.langer.1994.1">Langer et al 1994</a>]:</p><ul><li class="half_rhythm"><div>Disproportionate short stature</div></li><li class="half_rhythm"><div>Vertebral anomalies with block vertebrae</div></li><li class="half_rhythm"><div>Scoliosis, lordosis</div></li><li class="half_rhythm"><div>Carpal and tarsal synostosis</div></li><li class="half_rhythm"><div>Club feet</div></li><li class="half_rhythm"><div>Mild facial dysmorphisms with round face, frontal bossing, anteverted nares</div></li></ul><p>Other manifestations can include the following:</p><ul><li class="half_rhythm"><div>Midline cleft palate</div></li><li class="half_rhythm"><div>Conductive hearing loss</div></li><li class="half_rhythm"><div>Joint laxity</div></li><li class="half_rhythm"><div>Dental enamel hypoplasia</div></li></ul><p>Diagnostic radiographic features:</p><ul><li class="half_rhythm"><div class="half_rhythm">Fusion of adjacent vertebrae and posterior elements that can involve noncontiguous areas of the cervical, thoracic, and lumbar spine</div><div class="half_rhythm">Note: (1) Asymmetric fusion of the posterior elements can result in "a unilateral unsegmented vertebral bar." (2) More complex bilateral and midline-fused structures have also been reported. (3) Although frequently referred to as "segmentation defects," it is probable that the process of segmentation is normal in SCT syndrome and that the fusion of adjacent vertebral elements relates to a defect in a separate morphologic process that occurs later in development.</div></li></ul><p>&#x02022; Carpal and tarsal synostosis. Carpal synostosis is usually capitate-hamate and lunate-triquetrum [<a class="bk_pop" href="#flnb-dis.REF.langer.1994.1">Langer et al 1994</a>].</p><ul><li class="half_rhythm"><div>Delayed ossification of epiphyses (especially of carpal bones) and bilateral epiphyseal dysplasia of the femur; reported in two individuals [<a class="bk_pop" href="#flnb-dis.REF.honeywell.2002.318">Honeywell et al 2002</a>, <a class="bk_pop" href="#flnb-dis.REF.mitter.2008.779">Mitter et al 2008</a>]</div></li></ul><p><b>Larsen syndrome</b> is characterized by the following [<a class="bk_pop" href="#flnb-dis.REF.larsen.1950.574">Larsen et al 1950</a>]:</p><ul><li class="half_rhythm"><div>Congenital dislocations of the hip, knee, elbow, and (occasionally) the shoulder</div></li><li class="half_rhythm"><div>Club feet (equinovarus or equinovalgus foot deformities)</div></li><li class="half_rhythm"><div>Scoliosis and cervical kyphosis, which can be associated with a cervical myelopathy</div></li><li class="half_rhythm"><div>Short, broad, spatulate distal phalanges, particularly of the thumb</div></li><li class="half_rhythm"><div>Craniofacial anomalies (prominent forehead, depressed nasal bridge, malar flattening, and widely spaced eyes)</div></li></ul><p>Other manifestations can include the following:</p><ul><li class="half_rhythm"><div>Midline cleft palate</div></li><li class="half_rhythm"><div>Hearing loss, often resulting from malformations of the ossicles</div></li></ul><p>Diagnostic radiographic features in early childhood:</p><ul><li class="half_rhythm"><div>Supernumerary (accessory) carpal and tarsal bone ossification centers; possibly a universal finding [<a class="bk_pop" href="#flnb-dis.REF.bicknell.2007.89">Bicknell et al 2007</a>]</div></li></ul><p><b>Atelosteogenesis type I (AOI) and atelosteogenesis type III (AOIII),</b> once thought to represent distinct entities, now appear to be part of a phenotypic continuum [<a class="bk_pop" href="#flnb-dis.REF.farringtonrock.2006.705">Farrington-Rock et al 2006</a>].</p><ul><li class="half_rhythm"><div>AOIII is milder than AOI, commonly with survival beyond the neonatal period. Clinical findings are dislocated hips, knees, and elbows and club feet. Radiographic features include distal tapering of the humeri and femora, short and broad tubular bones of the hands and feet, and mild vertebral hypoplasia.</div></li><li class="half_rhythm"><div>AOI is characterized by perinatal lethality with severe short-limbed dwarfism, dislocated hips, knees, and elbows, and club feet. Radiographic features include marked platyspondyly; hypoplastic pelvis; incomplete or absent, shortened, or distally tapered humeri and femora; absent, shortened, or bowed radii; shortened and bowed ulnae and tibiae; absent fibulae; and unossified or partially ossified metacarpals and middle and proximal phalanges.</div></li></ul><p><b>Boomerang dysplasia</b> is a perinatal lethal bone dysplasia with close similarities to AOI, distinguished primarily by characteristic bowing of the femora and, occasionally, extraskeletal manifestations including encephalocele and omphalocele [<a class="bk_pop" href="#flnb-dis.REF.bicknell.2005.e43">Bicknell et al 2005</a>].</p></div><div id="flnb-dis.Molecular_Genetic_Testing"><h3>Molecular Genetic Testing</h3><p><b>Gene.</b>
<i>FLNB</i> is the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants cause the <i>FLNB-</i>related disorders [<a class="bk_pop" href="#flnb-dis.REF.krakow.2004.405">Krakow et al 2004</a>].</p><p>Several recurrent pathogenic variants have been reported (see <a href="#flnb-dis.GenotypePhenotype_Correlations">Genotype/Phenotype Correlations</a> and <a href="#flnb-dis.Molecular_Genetics">Molecular Genetics</a>).</p><div id="flnb-dis.T.molecular_genetic_testing_use" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>FLNB</i>-Related Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK2534/table/flnb-dis.T.molecular_genetic_testing_use/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__flnb-dis.T.molecular_genetic_testing_use_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_flnb-dis.T.molecular_genetic_testing_use_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_flnb-dis.T.molecular_genetic_testing_use_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_flnb-dis.T.molecular_genetic_testing_use_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variants Detected&#x000a0;<sup>2</sup></th><th id="hd_h_flnb-dis.T.molecular_genetic_testing_use_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Detection Frequency by Method&#x000a0;<sup>3</sup></th></tr></thead><tbody><tr><td headers="hd_h_flnb-dis.T.molecular_genetic_testing_use_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>FLNB</i></td><td headers="hd_h_flnb-dis.T.molecular_genetic_testing_use_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis of <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> or select exons&#x000a0;<sup>4</sup></td><td headers="hd_h_flnb-dis.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td><td headers="hd_h_flnb-dis.T.molecular_genetic_testing_use_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%&#x000a0;<sup>5,&#x000a0;6</sup></td></tr><tr><td headers="hd_h_flnb-dis.T.molecular_genetic_testing_use_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>7</sup></td><td headers="hd_h_flnb-dis.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Exon or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a></td><td headers="hd_h_flnb-dis.T.molecular_genetic_testing_use_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown; none reported&#x000a0;<sup>8</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="flnb-dis.TF.1.1"><p class="no_margin">See <a href="/books/NBK2534/#flnb-dis.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="flnb-dis.TF.1.2"><p class="no_margin">See <a href="#flnb-dis.Molecular_Genetics">Molecular Genetics</a> and <a href="#flnb-dis.GenotypePhenotype_Correlations">Genotype/Phenotype Correlations</a> for information on allelic variants.</p></div></dd><dt>3. </dt><dd><div id="flnb-dis.TF.1.3"><p class="no_margin">The ability of the test method used to detect a variant that is present in the indicated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a></p></div></dd><dt>4. </dt><dd><div id="flnb-dis.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="flnb-dis.TF.1.5"><p class="no_margin">Because this disorder is defined by the presence of a causative <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FLNB</i>, the variant detection frequency is 100%.</p></div></dd><dt>6. </dt><dd><div id="flnb-dis.TF.1.6"><p class="no_margin">Variant detection frequency for Larsen syndrome, AOI, and AOIII is 100%. In several instances individuals with typical SCT syndrome have had no <i>FLNB</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified on <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>; the proportion of such cases that could be explained by either <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions or <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> heterogeneity is unknown; however, some cases of SCT syndrome do not map to the <i>FLNB</i> locus using linkage analysis [Author, unpublished data].</p></div></dd><dt>7. </dt><dd><div id="flnb-dis.TF.1.7"><p class="no_margin">Testing that identifies deletions/duplications not readily detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>8. </dt><dd><div id="flnb-dis.TF.1.8"><p class="no_margin">No deletions or duplications involving <i>FLNB</i> have been reported to cause <i>FLNB</i>-related disorders.</p></div></dd></dl></div></div></div></div><div id="flnb-dis.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Perform <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> to identify a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FLNB</i>.</p><p>Clinical findings guide the order of testing of <i>FLNB</i> exons:</p><ul><li class="half_rhythm"><div>Pathogenic variants associated with the most severe phenotypes almost invariably occur in exons 2-5.</div></li><li class="half_rhythm"><div>Pathogenic variants associated with the milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, Larsen syndrome, can occur in exons 2-5 and exons 27-33.</div></li><li class="half_rhythm"><div>Sequencing of the entire <i>FLNB</i> <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> may be appropriate when clinical suspicion is high and a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was not identified in select exons.</div></li></ul><p><b>Carrier testing for relatives at risk for SCT syndrome</b> requires prior identification of the pathogenic variants in the family.</p><p>Note: SCT syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner; heterozygotes for <i>FLNB</i> pathogenic variants causing SCT syndrome are asymptomatic. All other <i>FLNB</i>-related disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner and, thus, <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> is not an issue.</p><p><b>Prenatal diagnosis</b> for at-risk pregnancies requires prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in the family.</p></div></div><div id="flnb-dis.Clinical_Characteristics"><h2 id="_flnb-dis_Clinical_Characteristics_">Clinical Characteristics</h2><div id="flnb-dis.Clinical_Description"><h3>Clinical Description</h3><p><b>Boomerang dysplasia or atelosteogenesis type I.</b> On prenatal ultrasound examination, the findings of boomerang dysplasia and AOI consist of thoracic hypoplasia and limb shortening with delayed or absent ossification of vertebral and appendicular elements. Joint dislocations may be evident. Definitive diagnosis by ultrasound examination alone is possible [<a class="bk_pop" href="#flnb-dis.REF.tsutsumi.2012.216">Tsutsumi et al 2012</a>]. Polyhydramnios can complicate the pregnancy. Neonates with boomerang dysplasia or AOI die soon after birth from cardiorespiratory insufficiency.</p><p><b>Atelosteogenesis type III.</b> The most conspicuous finding of AOIII is joint dislocations. A specific diagnosis of AOIII is seldom possible by ultrasound examination alone.</p><p>Infants with AOIII can survive the neonatal period but can require intensive and invasive support to do so. The infant reported by <a class="bk_pop" href="#flnb-dis.REF.schultz.1999.28">Schultz et al [1999]</a> had significant problems with respiratory insufficiency as a result of laryngotracheomalacia and thoracic hypoplasia. Her mother, who was intellectually normal, had similar but milder respiratory problems in the neonatal period.</p><p>Infants with AOIII have been born to parents with milder phenotypes (similar to Larsen syndrome). In these instances, the parents probably have a mild <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> associated with <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a>, whereas their offspring with a non-mosaic <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have a severe phenotype.</p><p>Developmental delay, present in some long-term survivors with AOIII, is assumed to be a secondary consequence of orthopedic and respiratory complications of the primary disorder</p><p><b>Spondylocarpotarsal synostosis syndrome.</b> Individuals with spondylocarpotarsal syndrome have normal or near-normal birth length; however, progressive vertebral fusion results in poor growth of the trunk and short stature becomes evident postnatally. Stature is typically -3 to -4 SD.</p><p>Scoliosis is common, but variable in severity and time of onset because of the extent and pattern of vertebral fusion. Some authors have observed deformity at birth although the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and, hence the diagnosis, has only become evident later in childhood. The irregular nature of the vertebral anomalies can also give rise to other complications such as cervical spine instability [<a class="bk_pop" href="#flnb-dis.REF.seaver.2000.340">Seaver &#x00026; Boyd 2000</a>].</p><p>SCT syndrome has been associated with retinal anomalies [<a class="bk_pop" href="#flnb-dis.REF.steiner.2000.131">Steiner et al 2000</a>] and sensorineural deafness [<a class="bk_pop" href="#flnb-dis.REF.langer.1994.1">Langer et al 1994</a>, <a class="bk_pop" href="#flnb-dis.REF.co_lho.1998.12">Co&#x000ea;lho et al 1998</a>]. The cataracts and retinal abnormalities described in one family with SCT syndrome were not severe enough to impair vision [<a class="bk_pop" href="#flnb-dis.REF.steiner.2000.131">Steiner et al 2000</a>].</p><p>Other findings can include pes planus, dental enamel hypoplasia, and unilateral conductive hearing loss [<a class="bk_pop" href="#flnb-dis.REF.mitter.2008.779">Mitter et al 2008</a>].</p><p>Intelligence is normal.</p><p>Note: Not all cases of spondylocarpotarsal syndrome as it is defined here have identifiable pathogenic variants in <i>FLNB</i>. One family with features of SCT with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> transmission has been described [<a class="bk_pop" href="#flnb-dis.REF.isidor.2008.1593">Isidor et al 2008</a>].</p><p><b>Larsen syndrome.</b> Larsen syndrome is compatible with survival into adulthood [<a class="bk_pop" href="#flnb-dis.REF.bicknell.2007.89">Bicknell et al 2007</a>]. Intelligence is normal.</p><p>Intrafamilial variation in Larsen syndrome can be remarkable. In a large family segregating one of the recurring pathogenic variants leading to Larsen syndrome, some individuals had cleft palate and multiple large joint dislocations, whereas others who had no major anomalies had short stature and very mild clinical and radiographic features, such as short distal phalanges and supernumerary carpal and tarsal bones [<a class="bk_pop" href="#flnb-dis.REF.bicknell.2007.89">Bicknell et al 2007</a>]. Clinical variability can also result from the presence of <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for a causative <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent and the presence of a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variant in more severely affected offspring.</p><p>In their study of 20 unrelated families with a total of 52 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, <a class="bk_pop" href="#flnb-dis.REF.bicknell.2007.89">Bicknell et al [2007]</a> determined that all probands had dislocations or subluxations of the large joints (80% hip, 80% knee, and 65% elbow). The most mildly affected <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> had subluxation of the shoulders as her only large joint manifestation. Clubfoot was present in 75% of affected individuals.</p><p>Stature is mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. In 14 of 20 probands height was below the tenth centile; height less than the first centile was rare and in one individual was greater than the 97th centile [<a class="bk_pop" href="#flnb-dis.REF.bicknell.2007.89">Bicknell et al 2007</a>].</p><p>Spinal abnormalities were observed on x-rays in 16 of 19 (84%) probands. Cervical kyphosis was noted in 50%, usually from subluxation or fusion of the bodies of C2, C3, and C4, which was commonly associated with posterior vertebral arch dysraphism (i.e., dysplasia of the vertebral laminae and hypoplasia of the lateral processes of all cervical vertebrae). Individuals with Larsen syndrome and cervical spine dysplasia are at significant risk for cervical cord myelopathy and secondary tetraparesis [<a class="bk_pop" href="#flnb-dis.REF.bicknell.2007.89">Bicknell et al 2007</a>]. The incidence of myelopathy is at least 15%.</p><p>Cleft palate occurs in 15% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p><p>Deafness is common [<a class="bk_pop" href="#flnb-dis.REF.herrmann.1981.45">Herrmann et al 1981</a>, <a class="bk_pop" href="#flnb-dis.REF.stanley.1988.395">Stanley et al 1988</a>, <a class="bk_pop" href="#flnb-dis.REF.maack.1991.51">Maack &#x00026; Muntz 1991</a>]. Conductive deafness, often with malformation of the ossicles of the middle ear, was observed in four of 19 probands (21%) [<a class="bk_pop" href="#flnb-dis.REF.bicknell.2007.89">Bicknell et al 2007</a>].</p><p>Although laryngotracheomalacia has been reported in association with Larsen syndrome, few individuals with Larsen syndrome and a documented <i>FLNB</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. Of note, individuals with more severe skeletal manifestations consistent with a diagnosis of AOIII can have severe laryngotracheomalacia [<a class="bk_pop" href="#flnb-dis.REF.rock.1988.55">Rock et al 1988</a>, <a class="bk_pop" href="#flnb-dis.REF.schultz.1999.28">Schultz et al 1999</a>].</p></div><div id="flnb-dis.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p><b>SCT syndrome.</b> Homozygosity or compound heterozygosity for pathogenic frameshift or <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants in <i>FLNB</i> causes SCT syndrome [<a class="bk_pop" href="#flnb-dis.REF.krakow.2004.405">Krakow et al 2004</a>]. Pathogenic variants associated with SCT syndrome are associated with loss of protein expression and hence are true <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> alleles [<a class="bk_pop" href="#flnb-dis.REF.farringtonrock.2006.705">Farrington-Rock et al 2006</a>].</p><p><b>Larsen syndrome and atelosteogenesis I and III.</b> The pathogenic variants associated with Larsen syndrome and AOII and AOIII are either <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants or small <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> deletions and are predicted to encode full-length filamin B protein.</p><p>Larson syndrome-associated pathogenic variants are spread over exons 2-5 and 27-33 [<a class="bk_pop" href="#flnb-dis.REF.bicknell.2007.89">Bicknell et al 2007</a>]. Atelosteogenesis type III-causing pathogenic variants are in exons 2-5, 13, and 27-33 [<a class="bk_pop" href="#flnb-dis.REF.farringtonrock.2006.705">Farrington-Rock et al 2006</a>].</p><p>The large majority of pathogenic variants reported in boomerang dysplasia and AOI are in exons 2-5 [<a class="bk_pop" href="#flnb-dis.REF.bicknell.2005.e43">Bicknell et al 2005</a>].</p><p>In some instances the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is associated with different phenotypes (e.g., <a class="figpopup" href="/books/NBK2534/table/flnb-dis.T.selected_flnb_pathogenic_vari/?report=objectonly" target="object" rid-figpopup="figflnbdisTselectedflnbpathogenicvari" rid-ob="figobflnbdisTselectedflnbpathogenicvari">c.502G&#x0003e;A</a> leading to the substitution <a class="figpopup" href="/books/NBK2534/table/flnb-dis.T.selected_flnb_pathogenic_vari/?report=objectonly" target="object" rid-figpopup="figflnbdisTselectedflnbpathogenicvari" rid-ob="figobflnbdisTselectedflnbpathogenicvari">p.Gly168Ser</a> is associated with both AOI and AOIII).</p><p>Recurrent pathogenic variants:</p><ul><li class="half_rhythm"><div>p.Gly1691Ser, the most common recurrent substitution, associated with phenotypes ranging from mild Larsen syndrome (<a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> bilateral dislocation of the knees and digital and craniofacial anomalies) to AOIII [<a class="bk_pop" href="#flnb-dis.REF.bicknell.2005.e43">Bicknell et al 2005</a>, <a class="bk_pop" href="#flnb-dis.REF.farringtonrock.2006.705">Farrington-Rock et al 2006</a>]</div></li><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK2534/table/flnb-dis.T.selected_flnb_pathogenic_vari/?report=objectonly" target="object" rid-figpopup="figflnbdisTselectedflnbpathogenicvari" rid-ob="figobflnbdisTselectedflnbpathogenicvari">c.679G&#x0003e;A</a>, predicting the substitution <a class="figpopup" href="/books/NBK2534/table/flnb-dis.T.selected_flnb_pathogenic_vari/?report=objectonly" target="object" rid-figpopup="figflnbdisTselectedflnbpathogenicvari" rid-ob="figobflnbdisTselectedflnbpathogenicvari">p.Glu227Lys</a>, associated with Larsen syndrome</div></li></ul><p><b>Mosaicism.</b> Clinical evidence suggests that <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> can complicate the presentation of these conditions [<a class="bk_pop" href="#flnb-dis.REF.petrella.1993.187">Petrella et al 1993</a>]. Most notably, somatic mosaicism for an <i>FLNB</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> can be associated with Larsen syndrome, whereas the same pathogenic variant in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> state can be associated with AOIII.</p></div><div id="flnb-dis.Penetrance"><h3>Penetrance</h3><p>Germline <i>FLNB</i> pathogenic variants are fully penetrant but show <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a>, leading to the range of phenotypes described in this <i>GeneReview</i>.</p></div><div id="flnb-dis.Nomenclature"><h3>Nomenclature</h3><p><b>Larsen syndrome</b>. Some authors described what appeared to be <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> Larsen syndrome [<a class="bk_pop" href="#flnb-dis.REF.claytonsmith.1988.499">Clayton-Smith &#x00026; Donnai 1988</a>, <a class="bk_pop" href="#flnb-dis.REF.bonaventure.1992.465">Bonaventure et al 1992</a>, <a class="bk_pop" href="#flnb-dis.REF.laville.1994.63">Laville et al 1994</a>, <a class="bk_pop" href="#flnb-dis.REF.yamaguchi.1996.75">Yamaguchi et al 1996</a>]; however, some of these families had sib recurrence of Larsen syndrome as a result of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in an unaffected parent [<a class="bk_pop" href="#flnb-dis.REF.petrella.1993.187">Petrella et al 1993</a>].</p><p>In contrast, other recessive disorders with multiple joint dislocations called Larsen syndrome in the past but not sharing other clinical characteristics of Larsen syndrome are best not referred to as Larsen syndrome [<a class="bk_pop" href="#flnb-dis.REF.topley.1994.263">Topley et al 1994</a>]. These conditions include the &#x0201c;Reunion Island form of Larsen syndrome&#x0201d; [<a class="bk_pop" href="#flnb-dis.REF.bonaventure.1992.465">Bonaventure et al 1992</a>, <a class="bk_pop" href="#flnb-dis.REF.laville.1994.63">Laville et al 1994</a>], which is clinically and radiographically distinct from <i>FLNB</i>-related Larsen syndrome.</p><p><b>Atelosteogenesis types I and III</b> were so named because the major manifestation is disordered and incomplete ossification of the skeleton [<a class="bk_pop" href="#flnb-dis.REF.maroteaux.1982.15">Maroteaux et al 1982</a>, <a class="bk_pop" href="#flnb-dis.REF.sillence.1982.7">Sillence et al 1982</a>, <a class="bk_pop" href="#flnb-dis.REF.stern.1990.183">Stern et al 1990</a>].</p><p>Note: Atelosteogenesis type II, one of the sulfate transporter-related osteochondrodysplasias caused by pathogenic variants in <i>SLC26A2 (DTDST</i>), is genetically distinct from AOI and AOIII (see <a href="/books/n/gene/ao2/">Atelosteogenesis Type II</a>).</p><p><b>Piepkorn dysplasia</b> is considered to be the same as boomerang dysplasia and, thus, the name has fallen out of use.</p></div><div id="flnb-dis.Prevalence"><h3>Prevalence</h3><p>No prevalence figures are available for any of the <i>FLNB</i>-related conditions.</p></div></div><div id="flnb-dis.Genetically_Related_Allelic_Dis"><h2 id="_flnb-dis_Genetically_Related_Allelic_Dis_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>FLNB</i>.</p></div><div id="flnb-dis.Differential_Diagnosis"><h2 id="_flnb-dis_Differential_Diagnosis_">Differential Diagnosis</h2><div id="flnb-dis.SCT_Syndrome"><h3>SCT Syndrome</h3><p>Other vertebral dysplasias with similarities to SCT syndrome, including spondylocostal dysplasia and multiple synostosis, are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Absence of rib anomalies in SCT syndrome distinguishes it from spondylocostal dysplasia; lack of progressive symphalangism and different facial findings in SCT syndrome distinguish it from multiple synostoses syndrome.</p><p>Some individuals with vertebral, carpal, and tarsal fusions similar to the findings of SCT syndrome, previously identified as having Klippel-Feil syndrome, have been shown to be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for pathogenic variants in <i>GDF6</i> [<a class="bk_pop" href="#flnb-dis.REF.tassabehji.2008.1017">Tassabehji et al 2008</a>].</p><p>Individuals with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance of a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> similar to <i>FLNB</i>-associated SCT syndrome but without identifiable <i>FLNB</i> pathogenic variants have been reported [<a class="bk_pop" href="#flnb-dis.REF.isidor.2008.1593">Isidor et al 2008</a>].</p></div><div id="flnb-dis.Larsen_Syndrome"><h3>Larsen Syndrome</h3><p><b>Otopalatodigital syndrome type 1 (OPD1)</b> (see <a href="/books/n/gene/opd/">Otopalatodigital Spectrum Disorders</a>) differs chiefly from Larsen syndrome in the following ways:</p><ul><li class="half_rhythm"><div><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance of OPD1</div></li><li class="half_rhythm"><div>Absence of dislocation of the large joints (except dislocation of the radial heads) and cervical spine dysplasia in OPD1</div></li><li class="half_rhythm"><div>Absence of radiologically supernumerary ossification centers within the carpus and/or tarsus in OPD1</div></li></ul><p>Other <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> conditions with prominent clinical manifestations relating to large joint dislocations also have distinguishing clinical and radiographic features that make them distinct from <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <i>FLNB</i>-related Larsen syndrome. These include:</p><p><a href="/books/n/gene/cd-chst3/"><b><i>CHST3</i>-related skeletal dysplasia</b></a> (also known as spondyloepiphyseal dysplasia, Omani type [<a class="bk_pop" href="#flnb-dis.REF.thiele.2004.10155">Thiele et al 2004</a>]) is characterized by short stature of prenatal onset, joint dislocations (knees, hips, radial heads), club feet, and limitation of range of motion that can involve all large joints. Kyphosis and occasionally scoliosis with slight shortening of the trunk develop in childhood. Minor heart valve dysplasia has been described in several persons. Intellect, vision, and hearing are normal. The chief differences are the presence of the following in <i>CHST3</i>-related skeletal dysplasia and not in Larsen syndrome:</p><ul><li class="half_rhythm"><div>Epiphyseal dysplasia</div></li><li class="half_rhythm"><div>Progressive spondylodysplasia in early and mid-childhood</div></li><li class="half_rhythm"><div>Rhizomelic shortening of the limbs</div></li></ul><p><b>Desbuquois dysplasia</b> is a chondrodysplasia in which <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have severe prenatal and postnatal growth retardation, progressive scoliosis, joint laxity, joint dislocations, and short extremities. A majority of affected individuals have <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>CANT1</i> [<a class="bk_pop" href="#flnb-dis.REF.huber.2009.706">Huber et al 2009</a>, <a class="bk_pop" href="#flnb-dis.REF.nizon.2012.1261">Nizon et al 2012</a>]. Desbuquois dysplasia differs from Larsen syndrome in the following ways:</p><ul><li class="half_rhythm"><div>Short stature (&#x0003c; -3 SD)</div></li><li class="half_rhythm"><div>Advanced carpal bone age</div></li><li class="half_rhythm"><div>Characteristic radiographic manifestations in the hips, pelvis, and hands</div></li></ul><p><b><i>B3GAT3</i> deficiency</b> [<a class="bk_pop" href="#flnb-dis.REF.baasanjav.2011.15">Baasanjav et al 2011</a>] is characterized by <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> facial features, short stature, bilateral dislocations of multiple joints (elbows, hips, and knees), club feet, and cardiovascular defects. Unlike Larsen syndrome, <i>B3GAT3</i> deficiency may include the following features:</p><ul><li class="half_rhythm"><div>Brachydactyly</div></li><li class="half_rhythm"><div>Cardiac defects, including bicuspid aortic valve and dilatation of the aorta.</div></li></ul><p><b>Chondrodysplasia with joint dislocations, GPAAP type</b>, is characterized by short stature, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> joint dislocations, chondrodysplasia with brachydactyly, <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> facial features, micrognathia, and cleft palate. This condition is caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>IMPAD1</i> [<a class="bk_pop" href="#flnb-dis.REF.vissers.2011.608">Vissers et al 2011</a>]. Differences from Larsen syndrome include the following:</p><ul><li class="half_rhythm"><div>Pronounced brachydactyly</div></li><li class="half_rhythm"><div>Asymmetry in the hands</div></li><li class="half_rhythm"><div>Short stature</div></li></ul></div></div><div id="flnb-dis.Management"><h2 id="_flnb-dis_Management_">Management</h2><div id="flnb-dis.Evaluations_Following_Initial_D"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>FLNB</i>-related disorders, the following evaluations are recommended if they have not already been completed.</p><p><b>Spondylocarpotarsal synostosis (SCT) syndrome</b></p><ul><li class="half_rhythm"><div>Ophthalmologic examination for retinal anomalies</div></li><li class="half_rhythm"><div>Audiometry to assess for sensorineural hearing loss</div></li><li class="half_rhythm"><div>Spine films to evaluate for vertebral abnormalities that predispose to scoliosis</div></li><li class="half_rhythm"><div>Cervical spine films to evaluate for cervical dysplasia</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul><p><b>Larsen syndrome</b></p><ul><li class="half_rhythm"><div class="half_rhythm">Lateral cervical spine films in flexion and extension to look for dysplasia that can lead to cervical cord myelopathy</div><div class="half_rhythm">Note: Early diagnosis of cervical kyphosis may influence the surgical approach used to stabilize the spine (see <a href="#flnb-dis.Treatment_of_Manifestations">Treatment of Manifestations</a>).</div></li><li class="half_rhythm"><div class="half_rhythm">Audiometry to assess hearing</div></li><li class="half_rhythm"><div class="half_rhythm">Assessment of the hips for dislocation</div></li></ul></div><div id="flnb-dis.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Cervical spine instability.</b> Case series indicate that early intervention to improve cervical spine stability in asymptomatic infants using posterior arthrodesis is successful. In infants with myelopathic signs function can be stabilized, if not improved, by a combination of anterior decompression and circumferential arthrodesis [<a class="bk_pop" href="#flnb-dis.REF.johnston.1996.538">Johnston et al 1996</a>, <a class="bk_pop" href="#flnb-dis.REF.sakaura.2007.e39">Sakaura et al 2007</a>, <a class="bk_pop" href="#flnb-dis.REF.madera.2008.320">Madera et al 2008</a>].</p><p><b>Large joint dislocations.</b> Conservative, nonsurgical management of hip dislocation in Larsen syndrome is often unsuccessful and operative reduction is usually required.</p><p><b>Scoliosis</b> is treated medically; no effective surgical intervention has been described.</p><p><b>Club feet</b> are managed in a routine manner.</p><p><b>Cleft palate</b> should be treated by a multidisciplinary craniofacial team when possible.</p><p><b>Hearing loss.</b> Ideally, the team evaluating and treating the deaf individual should consist of an otolaryngologist with expertise in the management of early childhood otologic disorders, an audiologist experienced in the assessment of hearing loss in children, a clinical geneticist, and a pediatrician. The expertise of an educator of the Deaf may also be required. An important part of the evaluation is determining the appropriate habilitation option. Possibilities include hearing aids, vibrotactile devices, and cochlear implantation (see <a href="/books/n/gene/deafness-overview/">Deafness and Hereditary Hearing Loss Overview</a>).</p></div><div id="flnb-dis.Prevention_of_Secondary_Complic"><h3>Prevention of Secondary Complications</h3><p>Evidence suggests that preemptive posterior stabilization of the cervical spine in individuals with Larsen syndrome with cervical spine dysplasia may prevent this complication and that combined anterior and posterior stabilization can lead to clinical improvement in individuals with evidence of myelopathy [<a class="bk_pop" href="#flnb-dis.REF.sakaura.2007.e39">Sakaura et al 2007</a>].</p><p>Because of the cervical vertebral abnormalities observed in both SCT syndrome and Larsen syndrome, the cervical spine should be evaluated for features of instability prior to general anesthesia. Care must be taken intraoperatively to minimize extension of the cervical spine [<a class="bk_pop" href="#flnb-dis.REF.malik.2002.632">Malik &#x00026; Choudhry 2002</a>, <a class="bk_pop" href="#flnb-dis.REF.critchley.2003.217">Critchley &#x00026; Chan 2003</a>]. Additionally, individuals with Larsen syndrome are at increased risk for airway complications related to laryngotracheomalacia; thus, it has been suggested that anesthetic agents that exhibit more rapid induction and recovery are preferred [<a class="bk_pop" href="#flnb-dis.REF.morishima.2004.194">Morishima et al 2004</a>].</p></div><div id="flnb-dis.Surveillance"><h3>Surveillance</h3><p>Vertebral anomalies can lead to progressive scoliosis; orthopedic monitoring is therefore indicated.</p><p>If an individual with Larsen syndrome is born without dislocated hips, careful surveillance should be maintained to ensure that dislocation does not occur.</p></div><div id="flnb-dis.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#flnb-dis.Related_Genetic_Counseling_Issu">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="flnb-dis.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Delivery of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infant has the potential to be complicated by extended breech presentation due to dislocation of the hips and knees.</p></div><div id="flnb-dis.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="flnb-dis.Genetic_Counseling"><h2 id="_flnb-dis_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="flnb-dis.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>The <i>FLNB</i>-related disorders, AOI, AOIII, boomerang dysplasia, and Larsen syndrome, are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p><p>Spondylocarpotarsal synostosis (SCT) syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="flnb-dis.Autosomal_Dominant_Inheritance"><h3>Autosomal Dominant Inheritance &#x02012; Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Some individuals diagnosed with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <i>FLNB</i>-related disorder have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <i>FLNB</i>-related disorder may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by <i>de novo</i> pathogenic variants is unknown, although the vast majority of lethal <i>FLNB</i>-related conditions are the result of <i>de novo</i> events, the exception being a low-grade mosaic parent transmitting the causative pathogenic variant to their <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> offspring.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the DNA of either parent, two possible explanations are <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent or a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband. Germline mosaicism has been reported; its incidence is unknown [<a class="bk_pop" href="#flnb-dis.REF.petrella.1993.187">Petrella et al 1993</a>].</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include a thorough clinical examination, which may include radiographic examination where indicated. Evaluation of parents may determine that one is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> but has escaped previous diagnosis because of failure by health care professionals to recognize the syndrome and/or a milder phenotypic presentation. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</div></li></ul><p>Note: (1) Although many individuals diagnosed with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <i>FLNB</i>-related disorder have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent, the family history may appear to be negative because of failure to recognize the disorder in family members. (2) If the parent is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the variant and may be mildly/minimally affected.</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband&#x02019;s parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the empiric <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is approximately 1% because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li><li class="half_rhythm"><div>Germline <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> has been reported; its incidence is unknown [<a class="bk_pop" href="#flnb-dis.REF.petrella.1993.187">Petrella et al 1993</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <i>FLNB</i>-related disorder has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the status of the proband's parents. If a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members may be at risk.</p></div><div id="flnb-dis.Autosomal_Recessive_Inheritance"><h3>Autosomal Recessive Inheritance</h3><div id="flnb-dis.Risk_to_Family_Members"><h4>Risk to Family Members</h4><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes and therefore carry one mutated <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic, although one case report has made an argument for the presence of mild manifestations in one instance.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Once an at-risk sib is known to be unaffected, the risk of his/her being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> is 2/3.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are generally asymptomatic.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with SCT syndrome are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FLNB</i>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each sib of the proband&#x02019;s parents is at 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>.</p></div><div id="flnb-dis.Carrier_Heterozygote_Detection"><h4>Carrier (Heterozygote) Detection</h4><p>Carrier testing for at-risk family members is possible once the pathogenic variants have been identified in the family.</p></div></div><div id="flnb-dis.Related_Genetic_Counseling_Issu"><h3>Related Genetic Counseling Issues</h3><p>Clinical evidence suggests that both <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> and <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> can complicate the presentation and recurrence risks associated with these conditions. Most notably, the presentation of a typical Larsen syndrome <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> can result from mosaicism for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> which, when present as a germline pathogenic variant, leads to the AOIII phenotype.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant or clinical evidence of the disorder, it is likely that the proband has a <i>de novo</i> pathogenic variant. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="flnb-dis.Prenatal_Testing_and_Preimplant"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>A priori high-risk pregnancies.</b> Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p><b>A priori low-risk pregnancies.</b> Routine prenatal ultrasound examination may identify skeletal findings such as limb changes consistent with multiple joint dislocations that raise the possibility of Larsen syndrome in a fetus not known to be at increased risk. Detection of fetuses <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with AOI by ultrasound examination during the second trimester is possible because of the multiple anomalies present including shortening of the limbs and thoracic hypoplasia [<a class="bk_pop" href="#flnb-dis.REF.ueno.2002.1071">Ueno et al 2002</a>].</p><p>Consideration of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for an <i>FLNB</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in these situations is appropriate.</p></div></div><div id="flnb-dis.Resources"><h2 id="_flnb-dis_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Children's Craniofacial Association (CCA)</b></div><div>13140 Coit Road</div><div>Suite 517</div><div>Dallas TX 75240</div><div><b>Phone:</b> 800-535-3643 (toll-free)</div><div><b>Email:</b> contactCCA@ccakids.com</div><div><a href="https://ccakids.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ccakids.org</a></div></li><li class="half_rhythm"><div><b>Compassionate Friends</b></div><div><i>Supporting Family After a Child Dies</i></div><div>PO Box 3696</div><div>Oak Brook IL 60522</div><div><b>Phone:</b> 877-969-0010 (toll free); 630-990-0010</div><div><b>Fax:</b> 630-990-0246</div><div><b>Email:</b> nationaloffice@compassionatefriends.org</div><div><a href="http://www.compassionatefriends.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.compassionatefriends.org</a></div></li><li class="half_rhythm"><div><b>Helping After Neonatal Death (HAND)</b></div><div>PO Box 341</div><div>Los Gatos CA 95031</div><div><b>Phone:</b> 888-908-HAND (4263)</div><div><b>Email:</b> info@handonline.org</div><div><a href="http://handonline.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.handonline.org</a></div></li><li class="half_rhythm"><div><b>Little People of America, Inc. (LPA)</b></div><div>250 El Camino Real</div><div>Suite 201</div><div>Tustin CA 92780</div><div><b>Phone:</b> 888-572-2001 (toll-free); 714-368-3689</div><div><b>Fax:</b> 714-368-3367</div><div><b>Email:</b> info@lpaonline.org</div><div><a href="http://www.lpaonline.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.lpaonline.org</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/ency/article/001241.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Scoliosis</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/ency/article/001228.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Clubfoot</a></div></li><li class="half_rhythm"><div><b>National Scoliosis Foundation (NSF)</b></div><div>5 Cabot Place</div><div>Stoughton MA 02072</div><div><b>Phone:</b> 800-673-6922 (toll-free)</div><div><b>Fax:</b> 781-341-8333</div><div><b>Email:</b> nsf@scoliosis.org</div><div><a href="http://www.scoliosis.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.scoliosis.org</a></div></li><li class="half_rhythm"><div><b>International Skeletal Dysplasia Registry</b></div><div>UCLA</div><div>615 Charles E. Young Drive</div><div>South Room 410</div><div>Los Angeles CA 90095-7358</div><div><b>Phone:</b> 310-825-8998</div><div><b>Fax:</b> 310-206-5266</div><div><b>Email:</b> Salon@mednet.ucla.edu</div><div><a href="https://www.uclahealth.org/ortho/isdr" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">International Skeletal Dysplasia Registry</a></div></li></ul></div><div id="flnb-dis.Molecular_Genetics"><h2 id="_flnb-dis_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="flnb-dis.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>FLNB-Related Disorders: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK2534/table/flnb-dis.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__flnb-dis.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_flnb-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_flnb-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_flnb-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_flnb-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_flnb-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_flnb-dis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_flnb-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2317" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FLNB</i></a></td><td headers="hd_b_flnb-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2317" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3p14<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_flnb-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O75369" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Filamin-B</a></td><td headers="hd_b_flnb-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/FLNB" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FLNB database</a></td><td headers="hd_b_flnb-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FLNB" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FLNB</a></td><td headers="hd_b_flnb-dis.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FLNB[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FLNB</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="flnb-dis.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="flnb-dis.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for FLNB-Related Disorders (<a href="/omim/108720,108721,112310,150250,272460,603381" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK2534/table/flnb-dis.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__flnb-dis.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/108720" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">108720</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ATELOSTEOGENESIS, TYPE I; AO1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/108721" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">108721</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ATELOSTEOGENESIS, TYPE III; AO3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/112310" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">112310</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">BOOMERANG DYSPLASIA; BOOMD</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/150250" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">150250</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LARSEN SYNDROME; LRS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/272460" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">272460</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603381" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603381</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FILAMIN B; FLNB</td></tr></tbody></table></div></div><div id="flnb-dis.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>The molecular pathogenesis of spondylocarpotarsal synostosis (SCT) syndrome results from a lack of expression of FLNB protein [<a class="bk_pop" href="#flnb-dis.REF.farringtonrock.2008.631">Farrington-Rock et al 2008</a>]. This mechanism differs from that of the Larsen syndrome &#x02013; atelosteogenesis (AO) spectrum of conditions, which are caused by normal expression of a structurally abnormal FLNB protein. The mechanism by which abnormal FLNB proteins lead to the Larsen syndrome-AO spectrum disorders in some instances is related to pathogenic variants leading to substitutions within the actin-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of the protein that confer enhanced avidity for actin [<a class="bk_pop" href="#flnb-dis.REF.sawyer.2009.1030">Sawyer et al 2009</a>]. These pathogenic variants are associated with the formation of foci of filamin protein in cells; however, how these relate to defective cellular function is still poorly understood. Pathogenic variants leading to substitutions in and around the hinge region of FLNB do not have the same effect as actin-binding domain substitutions in leading to concentrated cytoplasmic filamin B-containing foci [<a class="bk_pop" href="#flnb-dis.REF.daniel.2012.665">Daniel et al 2012</a>].</p><p>In the developing murine embryo Flnb is widely expressed, particularly in endothelial cells and chondrocytes. In keeping with this pattern of expression, Flnb-deficient mice are growth retarded with mild shortening of the limbs. Postnatally they develop fusion of the ribs and vertebrae, kyphoscoliosis, and malformations of the calvaria and facial bones. The possible mechanisms underlying this effect include diminished cell-matrix adhesion or de-repression of transforming growth factor beta signaling [<a class="bk_pop" href="#flnb-dis.REF.lu.2007.1661">Lu et al 2007</a>, <a class="bk_pop" href="#flnb-dis.REF.zheng.2007.121">Zheng et al 2007</a>, <a class="bk_pop" href="#flnb-dis.REF.zhou.2007.3919">Zhou et al 2007</a>, <a class="bk_pop" href="#flnb-dis.REF.farringtonrock.2008.631">Farrington-Rock et al 2008</a>].</p><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> transcript of <i>FLNB</i> is 9463 nucleotides in length and comprises 46 exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK2534/#flnb-dis.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Pathogenic variants associated with SCT syndrome are associated with loss of protein expression and hence are true <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> alleles [<a class="bk_pop" href="#flnb-dis.REF.farringtonrock.2006.705">Farrington-Rock et al 2006</a>]. The pathogenic variants associated with Larsen syndrome and AOI and AOIII are either <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants or small <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> deletions and are predicted to encode full-length filamin B protein. Pathogenic variants that lead to Larsen syndrome are clustered in exons 2-5 and 27-33 [<a class="bk_pop" href="#flnb-dis.REF.bicknell.2007.89">Bicknell et al 2007</a>]. Three recurrent pathogenic variants have been reported, the most common of which is p.Gly1691Ser (<a class="figpopup" href="/books/NBK2534/table/flnb-dis.T.selected_flnb_pathogenic_vari/?report=objectonly" target="object" rid-figpopup="figflnbdisTselectedflnbpathogenicvari" rid-ob="figobflnbdisTselectedflnbpathogenicvari">Table 2</a>) [<a class="bk_pop" href="#flnb-dis.REF.bicknell.2007.89">Bicknell et al 2007</a>].</p><div id="flnb-dis.T.selected_flnb_pathogenic_vari" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Selected <i>FLNB</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK2534/table/flnb-dis.T.selected_flnb_pathogenic_vari/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__flnb-dis.T.selected_flnb_pathogenic_vari_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phenotype</th><th id="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_1" rowspan="6" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">AOI</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.442T&#x0003e;A</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp148Arg</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_4" rowspan="30" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?db=nuccore&#x00026;id=105990513" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001457<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/entrez/viewer.fcgi?db=protein&#x00026;id=105990514" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001448<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.512T&#x0003e;A</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu171Gln</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.542G&#x0003e;T</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly181Val</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.549C&#x0003e;G</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys183Trp</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.608A&#x0003e;C</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln203Pro</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.4747_4749del</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp1583del</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_1" rowspan="5" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">AOIII</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.602C&#x0003e;T</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala201Val</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.629G&#x0003e;T</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly210Val</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.4804T&#x0003e;C</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser1602Pro</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.4927G&#x0003e;T</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala1643Ser</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.5071G&#x0003e;A</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly1691Ser&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">AOI or AOIII</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.502G&#x0003e;A&#x000a0;<sup>2</sup></td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly168Ser</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.4835G&#x0003e;A&#x000a0;<sup>2</sup></td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly1612Asp</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_1" rowspan="12" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Larsen syndrome</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.482T&#x0003e;G</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe161Cys</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.700C&#x0003e;G</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu234Val</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.679G&#x0003e;A</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu227Lys&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1081G&#x0003e;A</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly361Ser</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1088G&#x0003e;A</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly363Glu</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.4292T&#x0003e;G</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys1431Arg</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.4711_4713delAAT</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn1571del</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.4756G&#x0003e;A</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly1586Arg</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.4775T&#x0003e;A</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val1592Asp</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.4808C&#x0003e;T</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro1603Leu</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.5071G&#x0003e;A</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly1691Ser</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.5500G&#x0003e;A</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly1834Arg&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_1" rowspan="5" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">SCT syndrome</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1945C&#x0003e;T</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg649Ter</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.7029T&#x0003e;G</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr2343Ter</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2452C&#x0003e;T</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg818Ter</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.4819C&#x0003e;T</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg1607Ter</td></tr><tr><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.6408delC</td><td headers="hd_h_flnb-dis.T.selected_flnb_pathogenic_vari_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser2137LeufsTer5</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="flnb-dis.TF.2.1"><p class="no_margin">Recurrent pathogenic variants [<a class="bk_pop" href="#flnb-dis.REF.zhang.2006.e24">Zhang et al 2006</a>, <a class="bk_pop" href="#flnb-dis.REF.bicknell.2007.89">Bicknell et al 2007</a>]</p></div></dd><dt>2. </dt><dd><div id="flnb-dis.TF.2.2"><p class="no_margin">Pathogenic variants known to cause more than one <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a></p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The filamin-B protein comprises 2,602 amino acids. The N terminus has an actin-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>. The rest of the protein comprises 24 filamin repeats. There are two &#x0201c;hinge&#x0201d; regions between filamin repeats 15 and 16 and 23 and 24, which are thought to confer flexibility to the protein.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> For Larsen syndrome and AOI and AOIII, it is not known whether the pathogenic variants disrupt protein interactions or facilitate novel interactions with filamin B. The cause of SCT syndrome is a complete loss of filamin B protein.</p></div></div><div id="flnb-dis.References"><h2 id="_flnb-dis_References_">References</h2><div id="flnb-dis.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.baasanjav.2011.15">Baasanjav S, Al-Gazali L, Hashiguchi T, Mizumoto S, Fischer B, Horn D, Seelow D, Ali BR, Aziz SA, Langer R, Saleh AA, Becker C, N&#x000fc;rnberg G, Cantagrel V, Gleeson JG, Gomez D, Michel JB, Stricker S, Lindner TH, N&#x000fc;rnberg P, Sugahara K, Mundlos S, Hoffmann K. Faulty initiation of proteoglycan synthesis causes cardiac and joint defects. <span><span class="ref-journal">Am J Hum Genet. </span>2011;<span class="ref-vol">89</span>:15–27.</span> [<a href="/pmc/articles/PMC3135799/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3135799</span></a>] [<a href="/pubmed/21763480" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21763480</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.bicknell.2007.89">Bicknell LS, Farrington-Rock C, Shafeghati Y, Rump P, Alanay Y, Alembik Y, Al-Madani N, Firth H, Karimi-Nejad MH, Kim CA, Leask K, Maisenbacher M, Moran E, Pappas JG, Prontera P, de Ravel T, Fryns JP, Sweeney E, Fryer A, Unger S, Wilson LC, Lachman RS, Rimoin DL, Cohn DH, Krakow D, Robertson S. A molecular and clinical study of Larsen syndrome caused by mutations in FLNB. <span><span class="ref-journal">J Med Genet. </span>2007;<span class="ref-vol">44</span>:89–98.</span> [<a href="/pmc/articles/PMC2598053/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2598053</span></a>] [<a href="/pubmed/16801345" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16801345</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.bicknell.2005.e43">Bicknell LS, Morgan T, Bonaf&#x000e9; L, Wessels MW, Bialer MG, Willems PJ, Cohn DH, Krakow D, Robertson SP. Mutations in FLNB cause boomerang dysplasia. <span><span class="ref-journal">J Med Genet. </span>2005;<span class="ref-vol">42</span>:e43.</span> [<a href="/pmc/articles/PMC1736093/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1736093</span></a>] [<a href="/pubmed/15994868" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15994868</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.bonaventure.1992.465">Bonaventure J, Lasselin C, Mellier J, Cohen-Solal L, Maroteaux P. Linkage studies of four fibrillar collagen genes in three pedigrees with Larsen-like syndrome. <span><span class="ref-journal">J Med Genet. </span>1992;<span class="ref-vol">29</span>:465–70.</span> [<a href="/pmc/articles/PMC1016020/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1016020</span></a>] [<a href="/pubmed/1640425" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1640425</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.claytonsmith.1988.499">Clayton-Smith J, Donnai D. A further patient with the lethal type of Larsen syndrome. <span><span class="ref-journal">J Med Genet. </span>1988;<span class="ref-vol">25</span>:499–500.</span> [<a href="/pmc/articles/PMC1050530/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1050530</span></a>] [<a href="/pubmed/3172146" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3172146</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.co_lho.1998.12">Co&#x000ea;lho KE, Ramos ES, Felix TM, Martelli L, de Pina-Neto JM, Niikawa N. Three new cases of spondylocarpotarsal synostosis syndrome: clinical and radiographic studies. <span><span class="ref-journal">Am J Med Genet. </span>1998;<span class="ref-vol">77</span>:12–5.</span> [<a href="/pubmed/9557886" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9557886</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.critchley.2003.217">Critchley LA, Chan L. General anaesthesia in a child with Larsen syndrome. <span><span class="ref-journal">Anaesth Intensive Care. </span>2003;<span class="ref-vol">31</span>:217–20.</span> [<a href="/pubmed/12712791" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12712791</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.daniel.2012.665">Daniel PB, Morgan T, Alanay Y, Bijlsma E, Cho TJ, Cole T, Collins F, David A, Devriendt K, Faivre L, Ikegawa S, Jacquemont S, Jesic M, Krakow D, Liebrecht D, Maitz S, Marlin S, Morin G, Nishikubo T, Nishimura G, Prescott T, Scarano G, Shafeghati Y, Skovby F, Tsutsumi S, Whiteford M, Zenker M, Robertson SP. Disease-associated mutations in the actin-binding domain of filamin B cause cytoplasmic focal accumulations correlating with disease severity. <span><span class="ref-journal">Hum Mutat. </span>2012 Apr;<span class="ref-vol">33</span>(4):665–73.</span> [<a href="/pubmed/22190451" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22190451</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.farringtonrock.2006.705">Farrington-Rock C, Firestein MH, Bicknell LS, Superti-Furga A, Bacino CA, Cormier-Daire V, Le Merrer M, Baumann C, Roume J, Rump P, Verheij JB, Sweeney E, Rimoin DL, Lachman RS, Robertson SP, Cohn DH, Krakow D. Mutations in two regions of FLNB result in atelosteogenesis I and III. <span><span class="ref-journal">Hum Mutat. </span>2006;<span class="ref-vol">27</span>:705–10.</span> [<a href="/pubmed/16752402" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16752402</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.farringtonrock.2008.631">Farrington-Rock C, Kirilova V, Dillard-Telm L, Borowsky AD, Chalk S, Rock MJ, Cohn DH, Krakow D. Disruption of the Flnb gene in mice phenocopies the human disease spondylocarpotarsal synostosis syndrome. <span><span class="ref-journal">Hum Mol Genet. </span>2008;<span class="ref-vol">17</span>:631–41.</span> [<a href="/pmc/articles/PMC2680151/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2680151</span></a>] [<a href="/pubmed/17635842" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17635842</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.herrmann.1981.45">Herrmann HC, Kelly JH, Fried MP, Strome M. The association of a hearing deficit with Larsen&#x02019;s syndrome. <span><span class="ref-journal">J Otolaryngol. </span>1981;<span class="ref-vol">10</span>:45–8.</span> [<a href="/pubmed/7193744" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7193744</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.honeywell.2002.318">Honeywell C, Langer L, Allanson J. Spondylocarpotarsal synostosis with epiphyseal dysplasia. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">109</span>:318–22.</span> [<a href="/pubmed/11992487" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11992487</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.huber.2009.706">Huber C, Oul&#x000e8;s B, Bertoli M, Chami M, Fradin M, Alanay Y, Al-Gazali LI, Ausems MG, Bitoun P, Cavalcanti DP, Krebs A, Le Merrer M, Mortier G, Shafeghati Y, Superti-Furga A, Robertson SP, Le Goff C, Muda AO, Paterlini-Br&#x000e9;chot P, Munnich A, Cormier-Daire V. Identification of CANT1 mutations in Desbuquois dysplasia. <span><span class="ref-journal">Am J Hum Genet. </span>2009;<span class="ref-vol">85</span>:706–10.</span> [<a href="/pmc/articles/PMC2775828/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2775828</span></a>] [<a href="/pubmed/19853239" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19853239</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.isidor.2008.1593">Isidor B, Cormier-Daire V, Le Merrer M, Lefrancois T, Hamel A, Le Caignec C, David A, Jacquemont S. Autosomal dominant spondylocarpotarsal synostosis syndrome: phenotypic homogeneity and genetic heterogeneity. <span><span class="ref-journal">Am J Med Genet A. </span>2008;<span class="ref-vol">146A</span>:1593–7.</span> [<a href="/pubmed/18470895" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18470895</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.johnston.1996.538">Johnston CE 2nd, Birch JG, Daniels JL. Cervical kyphosis in patients who have Larsen syndrome. <span><span class="ref-journal">J Bone Joint Surg Am. </span>1996;<span class="ref-vol">78</span>:538–45.</span> [<a href="/pubmed/8609132" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8609132</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.krakow.2004.405">Krakow D, Robertson SP, King LM, Morgan T, Sebald ET, Bertolotto C, Wachsmann-Hogiu S, Acuna D, Shapiro SS, Tarafuta T, Aftimos S, Kim CA, Firth H, Steiner CE, Cormier-Daire V, Superti-Furga A, Bonaf&#x000e9; L, Graham JM, Grix A, Bacino CA, Allanson J, Bialer MG, Lachman RS, Rimoin DL, Cohn DH. Mutations in the gene encoding filamin B disrupt vertebral segmentation, joint formation and skeletogenesis. <span><span class="ref-journal">Nat Genet. </span>2004;<span class="ref-vol">36</span>:405–10.</span> [<a href="/pubmed/14991055" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14991055</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.langer.1994.1">Langer LO Jr, Gorlin RJ, Donnai D, Hamel BC, Clericuzio C. Spondylocarpotarsal synostosis syndrome (with or without unilateral unsegmented bar). <span><span class="ref-journal">Am J Med Genet. </span>1994;<span class="ref-vol">51</span>:1–8.</span> [<a href="/pubmed/8030662" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8030662</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.larsen.1950.574">Larsen LJ, Schottstaedt ER, Bost FC. Multiple congenital dislocations associated with characteristic facial abnormality. <span><span class="ref-journal">J Pediatr. </span>1950;<span class="ref-vol">37</span>:574–81.</span> [<a href="/pubmed/14779259" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14779259</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.laville.1994.63">Laville JM, Lakermance P, Limouzy F. Larsen&#x02019;s syndrome: review of the literature and analysis of thirty-eight cases. <span><span class="ref-journal">J Pediatr Orthop. </span>1994;<span class="ref-vol">14</span>:63–73.</span> [<a href="/pubmed/8113375" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8113375</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.lu.2007.1661">Lu J, Lian G, Lenkinski R, De Grand A, Vaid RR, Bryce T, Stasenko M, Boskey A, Walsh C, Sheen V. Filamin B mutations cause chondrocyte defects in skeletal development. <span><span class="ref-journal">Hum Mol Genet. </span>2007;<span class="ref-vol">16</span>:1661–75.</span> [<a href="/pubmed/17510210" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17510210</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.maack.1991.51">Maack RW, Muntz HR. Ossicular abnormality in Larsen's syndrome: a case report. <span><span class="ref-journal">Am J Otolaryngol. </span>1991;<span class="ref-vol">12</span>:51–3.</span> [<a href="/pubmed/2029067" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2029067</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.madera.2008.320">Madera M, Crawford A, Mangano FT. Management of severe cervical kyphosis in a patient with Larsen syndrome. Case report. <span><span class="ref-journal">J Neurosurg Pediatr. </span>2008;<span class="ref-vol">1</span>:320–4.</span> [<a href="/pubmed/18377309" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18377309</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.malik.2002.632">Malik P, Choudhry DK. Larsen syndrome and its anaesthetic considerations. <span><span class="ref-journal">Paediatr Anaesth. </span>2002;<span class="ref-vol">12</span>:632–6.</span> [<a href="/pubmed/12358662" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12358662</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.maroteaux.1982.15">Maroteaux P, Spranger J, Stanescu V, Le Marec B, Pfeiffer RA, Beighton P, Mattei JF. Atelosteogenesis. <span><span class="ref-journal">Am J Med Genet. </span>1982;<span class="ref-vol">13</span>:15–25.</span> [<a href="/pubmed/7137218" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7137218</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.mitter.2008.779">Mitter D, Krakow D, Farrington-Rock C, Meinecke P. Expanded clinical spectrum of spondylocarpotarsal synostosis syndrome and possible manifestation in a heterozygous father. <span><span class="ref-journal">Am J Med Genet A. </span>2008;<span class="ref-vol">146A</span>:779–83.</span> [<a href="/pubmed/18257094" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18257094</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.morishima.2004.194">Morishima T, Sobue K, Tanaka S, So M, Arima H, Ando H, Katsuya H. Sevoflurane for general anaesthetic management in a patient with Larsen syndrome. <span><span class="ref-journal">Paediatr Anaesth. </span>2004;<span class="ref-vol">14</span>:194–5.</span> [<a href="/pubmed/14962340" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14962340</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.nizon.2012.1261">Nizon M, Huber C, De Leonardis F, Merrina R, Forlino A, Fradin M, Tuysuz B, Abu-Libdeh BY, Alanay Y, Albrecht B, Al-Gazali L, Basaran SY, Clayton-Smith J, D&#x000e9;sir J, Gill H, Greally MT, Koparir E, van Maarle MC, MacKay S, Mortier G, Morton J, Sillence D, Vilain C, Young I, Zerres K, Le Merrer M, Munnich A, Le Goff C, Rossi A, Cormier-Daire V. Further delineation of CANT1 phenotypic spectrum and demonstration of its role in proteoglycan synthesis. <span><span class="ref-journal">Hum Mutat. </span>2012;<span class="ref-vol">33</span>:1261–6.</span> [<a href="/pmc/articles/PMC3427906/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3427906</span></a>] [<a href="/pubmed/22539336" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22539336</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.petrella.1993.187">Petrella R, Rabinowitz JG, Steinmann B, Hirschhorn K. Long-term follow-up of two sibs with Larsen syndrome possibly due to parental germ-line mosaicism. <span><span class="ref-journal">Am J Med Genet. </span>1993;<span class="ref-vol">47</span>:187–97.</span> [<a href="/pubmed/8213905" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8213905</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.rock.1988.55">Rock MJ, Green CG, Pauli RM, Peters ME. Tracheomalacia and bronchomalacia associated with Larsen syndrome. <span><span class="ref-journal">Pediatr Pulmonol. </span>1988;<span class="ref-vol">5</span>:55–9.</span> [<a href="/pubmed/3174275" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3174275</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.sakaura.2007.e39">Sakaura H, Matsuoka T, Iwasaki M, Yonenobu K, Yoshikawa H. Surgical treatment of cervical kyphosis in Larsen syndrome: Report of 3 cases and review of the literature. <span><span class="ref-journal">Spine. </span>2007;<span class="ref-vol">32</span>:E39–44.</span> [<a href="/pubmed/17202879" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17202879</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.sawyer.2009.1030">Sawyer GM, Clark AR, Robertson SP, Sutherland-Smith AJ. Disease-associated substitutions in the filamin B actin binding domain confer enhanced actin binding affinity in the absence of major structural disturbance: Insights from the crystal structures of filamin B actin binding domains. <span><span class="ref-journal">J Mol Biol. </span>2009;<span class="ref-vol">390</span>:1030–47.</span> [<a href="/pubmed/19505475" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19505475</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.schultz.1999.28">Schultz C, Langer LO, Laxova R, Pauli RM. Atelosteogenesis Type III: long-term survival, prenatal diagnosis, and evidence for dominant transmission. <span><span class="ref-journal">Am J Med Genet. </span>1999;<span class="ref-vol">83</span>:28–42.</span> [<a href="/pubmed/10076882" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10076882</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.seaver.2000.340">Seaver LH, Boyd E. Spondylocarpotarsal synostosis syndrome and cervical instability. <span><span class="ref-journal">Am J Med Genet. </span>2000;<span class="ref-vol">91</span>:340–4.</span> [<a href="/pubmed/10766994" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10766994</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.sillence.1982.7">Sillence DO, Lachman RS, Jenkins T, Riccardi VM, Rimoin DL. Spondlohumerofermoral hypoplasis (giant cell chondrodysplasia): a neonatally lethal short-limb skeletal dysplasia. <span><span class="ref-journal">Am J Med Genet. </span>1982;<span class="ref-vol">13</span>:7–14.</span> [<a href="/pubmed/6753583" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6753583</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.stanley.1988.395">Stanley CS, Thelin JW, Miles JH. Mixed hearing loss in Larsen syndrome. <span><span class="ref-journal">Clin Genet. </span>1988;<span class="ref-vol">33</span>:395–8.</span> [<a href="/pubmed/3378369" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3378369</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.steiner.2000.131">Steiner CE, Torriani M, Norato DY, Marques-de-Faria AP. Spondylocarpotarsal synostosis with ocular findings. <span><span class="ref-journal">Am J Med Genet. </span>2000;<span class="ref-vol">91</span>:131–4.</span> [<a href="/pubmed/10748412" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10748412</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.stern.1990.183">Stern HJ, Graham JM Jr, Lachman RS, Horton W, Bernini PM, Spiegel PK, Bodurtha J, Ives EJ, Bocian M, Rimoin DL. Atelosteogenesis type III: a distinct skeletal dysplasia with features overlapping atelosteogenesis and oto-palato-digital syndrome type II. <span><span class="ref-journal">Am J Med Genet. </span>1990;<span class="ref-vol">36</span>:183–95.</span> [<a href="/pubmed/2368807" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2368807</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.tassabehji.2008.1017">Tassabehji M, Fang ZM, Hilton EN, McGaughran J, Zhao Z, de Bock CE, Howard E, Malass M, Donnai D, Diwan A, Manson FD, Murrell D, Clarke RA. Mutations in GDF6 are associated with vertebral segmentation defects in Klippel-Feil syndrome. <span><span class="ref-journal">Hum Mutat. </span>2008;<span class="ref-vol">29</span>:1017–27.</span> [<a href="/pubmed/18425797" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18425797</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.thiele.2004.10155">Thiele H, Sakano M, Kitagawa H, Sugahara K, Rajab A, H&#x000f6;hne W, Ritter H, Leschik G, N&#x000fc;rnberg P, Mundlos S. Loss of chondroitin 6-O-sulfotransferase-1 function results in severe human chondrodysplasia with progressive spinal involvement. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2004;<span class="ref-vol">101</span>:10155–60.</span> [<a href="/pmc/articles/PMC454181/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC454181</span></a>] [<a href="/pubmed/15215498" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15215498</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.topley.1994.263">Topley JM, Varady E, Lestringant GG. Larsen syndrome in siblings with consanguineous parents. <span><span class="ref-journal">Clin Dysmorphol. </span>1994;<span class="ref-vol">3</span>:263–5.</span> [<a href="/pubmed/7526939" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7526939</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.tsutsumi.2012.216">Tsutsumi S, Maekawa A, Obata M, Morgan T, Robertson SP, Kurachi H. A case of boomerang dysplasia with a novel causative mutation in filamin B: identification of typical imaging findings on ultrasonography and 3D-CT imaging. <span><span class="ref-journal">Fetal Diagn Ther. </span>2012;<span class="ref-vol">32</span>:216–20.</span> [<a href="/pubmed/22354125" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22354125</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.ueno.2002.1071">Ueno K, Tanaka M, Miyakoshi K, Zhao C, Shinmoto H, Nishimura G, Yoshimura Y. Prenatal diagnosis of atelosteogenesis type I at 21 weeks' gestation. <span><span class="ref-journal">Prenat Diagn. </span>2002;<span class="ref-vol">22</span>:1071–5.</span> [<a href="/pubmed/12454961" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12454961</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.vissers.2011.608">Vissers LE, Lausch E, Unger S, Campos-Xavier AB, Gilissen C, Rossi A, Del Rosario M, Venselaar H, Knoll U, Nampoothiri S, Nair M, Spranger J, Brunner HG, Bonaf&#x000e9; L, Veltman JA, Zabel B, Superti-Furga A. Chondrodysplasia and abnormal joint development associated with mutations in IMPAD1, encoding the Golgi-resident nucleotide phosphatase, gPAPP. <span><span class="ref-journal">Am J Hum Genet. </span>2011;<span class="ref-vol">88</span>:608–15.</span> [<a href="/pmc/articles/PMC3146727/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3146727</span></a>] [<a href="/pubmed/21549340" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21549340</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.yamaguchi.1996.75">Yamaguchi K, Ogawa Y, Handa T. Brain dysplasia associated with Larsen-like syndrome. <span><span class="ref-journal">Pediatr Neurol. </span>1996;<span class="ref-vol">14</span>:75–9.</span> [<a href="/pubmed/8652025" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8652025</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.zhang.2006.e24">Zhang D, Herring JA, Swaney SS, McClendon TB, Gao X, Browne RH, Rathjen KE, Johnston CE, Harris S, Cain NM, Wise CA. Mutations responsible for Larsen syndrome cluster in the FLNB protein. <span><span class="ref-journal">J Med Genet. </span>2006;<span class="ref-vol">43</span>:e24.</span> [<a href="/pmc/articles/PMC2564529/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2564529</span></a>] [<a href="/pubmed/16648377" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16648377</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.zheng.2007.121">Zheng L, Baek HJ, Karsenty G, Justice MJ. Filamin B represses chondrocyte hypertrophy in a Runx2/Smad3-dependent manner. <span><span class="ref-journal">J Cell Biol. </span>2007;<span class="ref-vol">178</span>:121–8.</span> [<a href="/pmc/articles/PMC2064428/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2064428</span></a>] [<a href="/pubmed/17606870" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17606870</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="flnb-dis.REF.zhou.2007.3919">Zhou X, Tian F, Sandz&#x000e9;n J, Cao R, Flaberg E, Szekely L, Cao Y, Ohlsson C, Bergo MO, Bor&#x000e9;n J, Aky&#x000fc;rek LM. Filamin B deficiency in mice results in skeletal malformations and impaired microvascular development. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2007;<span class="ref-vol">104</span>:3919–24.</span> [<a href="/pmc/articles/PMC1820684/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1820684</span></a>] [<a href="/pubmed/17360453" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17360453</span></a>]</div></li></ul></div></div><div id="flnb-dis.Chapter_Notes"><h2 id="_flnb-dis_Chapter_Notes_">Chapter Notes</h2><div id="flnb-dis.Author_Notes"><h3>Author Notes</h3><p>University of Otago Clinical Genetics Group <a href="http://dnmeds.otago.ac.nz/departments/womens/paediatrics/research/cgg/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">website</a></p></div><div id="flnb-dis.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>17 October 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>9 October 2008 (me) Review posted live</div></li><li class="half_rhythm"><div>20 May 2008 (sr) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK2534</span><span class="label">PMID: <a href="/pubmed/20301736" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301736</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/x-pvh/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/fragilex/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK2534&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK2534/?report=reader">PubReader</a></li><li><a href="/books/NBK2534/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK2534" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK2534" style="display:none" title="Cite this Page"><div class="bk_tt">Robertson S. FLNB-Related Disorders. 2008 Oct 9 [Updated 2013 Oct 17]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK2534/pdf/Bookshelf_NBK2534.pdf">PDF version of this page</a> (479K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#flnb-dis.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#flnb-dis.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#flnb-dis.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#flnb-dis.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#flnb-dis.Genetically_Related_Allelic_Dis" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#flnb-dis.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#flnb-dis.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#flnb-dis.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#flnb-dis.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#flnb-dis.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#flnb-dis.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#flnb-dis.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2317[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FLNB</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK2534+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1473840" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1473840" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1473840" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1473840" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24830047" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TRPV4</i>-Associated Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TRPV4</i>-Associated Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Schindler A, Sumner C, Hoover-Fong JE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29566257" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Seven additional families with spondylocarpotarsal synostosis syndrome with novel biallelic deleterious variants in FLNB.</a><span class="source">[Clin Genet. 2018]</span><div class="brieflinkpop offscreen_noflow">Seven additional families with spondylocarpotarsal synostosis syndrome with novel biallelic deleterious variants in FLNB.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Salian S, Shukla A, Shah H, Bhat SN, Bhat VR, Nampoothiri S, Shenoy R, Phadke SR, Hariharan SV, Girisha KM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clin Genet. 2018 Jul; 94(1):159-164. Epub 2018 Apr 14.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301472" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">COL1A1/2</i> Osteogenesis Imperfecta</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">COL1A1/2</i> Osteogenesis Imperfecta<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Steiner RD, Basel D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28739045" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Filamin B: The next hotspot in skeletal research?</a><span class="source">[J Genet Genomics. 2017]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Filamin B: The next hotspot in skeletal research?<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Xu Q, Wu N, Cui L, Wu Z, Qiu G. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Genet Genomics. 2017 Jul 20; 44(7):335-342. Epub 2017 Jul 6.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301306" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CLCN7</i>-Related Osteopetrosis</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CLCN7</i>-Related Osteopetrosis<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sobacchi C, Villa A, Schulz A, Kornak U. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301736" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301736" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04161cdde08911690d47cb">FLNB-Related Disorders - GeneReviews®</a><div class="ralinkpop offscreen_noflow">FLNB-Related Disorders - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:08:28-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE8976E9E040E5F10000000003F101C8&amp;ncbi_session=CE8976E9E04161C1_1009SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK2534%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK2534&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK2534/&amp;ncbi_pagename=FLNB-Related Disorders - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8976E9E04161C1_1009SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>